Will Use Of A Digital AI-guided Anamnestic Support Instrument And Use Of Digitally Monitoring Of Therapy Improve Headache Care And Outcome?

November 10, 2026 updated by: Region Stockholm

Hospital@Home Project WP 6 Migraine - Will Use of a Digital AI-guided Anamnestic Support Instrument and Use of Digitally Monitoring of Therapy Improve Headache Care and Outcome?

This study aims to:

Develop and validate a Headache Evaluation to support Anamnesis and Diagnostics (HEAD)-instrument for use to improve consultation time and support thorough headache anamnesis and history taking at the first specialist headache consultation (test study) addressing a well-documented gap in current care and directly operationalising the H@H principle of extending structured clinical support into the patient's pathway before hospital contact.

Improve headache care by providing a more digital longitudinal support from first visit and during follow up of chronic severe headache disorders, with primary focus on migraines, with better and more timely assessment of treatment response and disease burden to promote appropriate change of care regime (implementation study).

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Testing phase of the study developing the HEAD instrument: Patients attending headache clinics at the three sites (300 patients in total) will be included, 150 will be recruited for the development phase and 150 for the validation phase.

Implementation phase: Patients (300 patients in total - three recruiting sites) with new referal to the clinic will be included in the digital pathway including the HEAD instrument and digital follow-up questionnaires and headache diary. Depending on results for the testing phase this phase will be adjusted.

Description

Inclusion Criteria:

  • Patients referred to or already attending the clinic/department
  • Headache and/or facial pain is the primary reason for consultation

Exclusion Criteria:

  • Insufficient answered questionnaire - more than 30% missing data.
  • not having internet experience or access
  • insufficient native language knowledge

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: CASE_ONLY
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with symtoms of headache/facial pain

Patients seeking medical help at specialist care for headache or facial pain disorder, largest group of patients will be patients with migraine diagnosis

Using patients own input prior to first visit at a specialist center (by filling in a advanced on-line questionnaire) we intend to support the clinical visit so that the clinican will recieve an anamnestic summarise of the patients history by using a by project developed AI module which will also be validated in this study and integrated in a digital pathway in treating severe migraine and headache patients in specialised care enviroment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Headache diagnosis
Time Frame: 1,5 year

Provide a high agreement between the HEAD instruments output of diagnosis and treatment suggestions compared to reference standard (independent blinded medical record review and diagnosis and treatment standards)?

1,5 year
Headache anamnesis
Time Frame: 1,5 year

Produce a good summary of patients' anamnesis according to physicians?

1,5 year
Headache severity
Time Frame: 1,5 Year

Detect headache severity and thereby support earlier identification of patients at risk of migraine chronification?

1,5 Year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Userfriendliness
Time Frame: 1,5 year

Is the developed questionnaire and HEAD instrument user-friendly for physicians and patients based on a 7-point Likert scale answers?

1,5 year
Agreement with set diagnosis
Time Frame: 1,5 year

To what extent does the HEAD instrument show agreement with set diagnosis from clinicians?

1,5 year
Omission rate of HEAD instrument
Time Frame: 1,5 year

What is the omission rate or citation rate of the HEAD instrument (the diagnosis does not appear by the top three diagnosis suggestions from the HEAD instrument or appears in at least any of the three top three diagnosis suggestions)?

1,5 year
Time efficiency
Time Frame: 1,5 year

Does the HEAD instrument and digital follow up improve the use of consultation time and with higher quality for the physicians and patients?

1,5 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implementation study
Time Frame: 3 years

How well does a more digital pathway for migaine diagnosis, support and follow up improve the overall care for headache patients?

3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 15, 2027

Primary Completion (Estimated)

January 15, 2030

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • H@H_digitalHEAD
  • No 101252709 (Other Identifier: Innovative Health Initiative Joint Undertaking (IHI JU))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe